EverSource Wealth Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6K Buy
183
+15
+9% +$2.16K ﹤0.01% 2395
2025
Q4
$24K Buy
168
+27
+19% +$3.62K ﹤0.01% 2269
2025
Q3
$16.9K Sell
141
-111
-44% -$14.1K ﹤0.01% 2483
2025
Q2
$33.3K Buy
252
+42
+20% +$5.69K ﹤0.01% 1906
2025
Q1
$29.2K Buy
210
+103
+96% +$16K ﹤0.01% 1495
2024
Q4
$16.6K Buy
107
+9
+9% +$1.52K ﹤0.01% 1730
2024
Q3
$17.9K Hold
98
﹤0.01% 1551
2024
Q2
$12.4K Buy
98
+8
+9% +$842 ﹤0.01% 1738
2024
Q1
$8.81K Sell
90
-45
-33% -$4.47K ﹤0.01% 1758
2023
Q4
$13.5K Buy
135
+112
+487% +$11K ﹤0.01% 1424
2023
Q3
$2.74K Buy
23
+13
+130% +$1.94K ﹤0.01% 1918
2023
Q2
$1.78K Buy
10
+3
+43% +$550 ﹤0.01% 2063
2023
Q1
$1.16K Buy
7
+3
+75% +$516 ﹤0.01% 2076
2022
Q4
$630 Sell
4
-51
-93% -$7.76K ﹤0.01% 2172
2022
Q3
$8K Buy
+55
New +$9.15K ﹤0.01% 1198

Other funds holding ICUI

EverSource Wealth Advisors's ICUI Position: Q1 2026 in Review

EverSource Wealth Advisors increased its ICU Medical (ICUI) stake by 8.9% in Q1 2026, buying an estimated $2.16K and bringing the position to 183 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

EverSource Wealth Advisors first reported a position in ICUI in Q3 2022 and has held it in 15 quarters since. The position peaked at $33.3K in Q2 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • EverSource Wealth Advisors held 183 shares of ICU Medical worth $23.6K as of Q1 2026.
  • EverSource Wealth Advisors bought 15 ICU Medical shares in Q1 2026, an estimated $2.16K.
  • ICU Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #2395 holding.
  • EverSource Wealth Advisors first reported a position in ICU Medical in Q3 2022 and has held it in 15 quarters since.
  • EverSource Wealth Advisors's ICU Medical position peaked at $33.3K in Q2 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.